About this trial
Controlling hemorrhage during and after a cesarean section reduces significantly maternal mortality and morbidity and the present study is important for detection of the effectiveness of routinely increasing the oxytocin dose instead of using the standard dose only in preventing postpartum hemorrhage and additional use of uterotonics in the first 24 hours after cesarean section for high risk pregnancy.
Eligibility criteria
Qualifiers
- Medical disorders ie: Hypertensive diseases with pregnancy - Diabetes Mellitus - Collagen diseases - Coagulopathies - Cardiac diseases - Anemia
History of postpartum hemorrhage
Placental disorders ie: placenta previa
Infertility and ICSI
Disqualifiers
- Oxytocin Allergy
Normal uncomplicated pregnancy
Emergency cesarean section
Exhausted uterus due to trial of normal labor
Trial design
Treatments tested in this trial
- Oxytocin